Literature DB >> 17366911

Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004).

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17366911     DOI： 10.1291/hypres.29.s1

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  37 in total

1.  The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet.

Authors:  Shizuka Aritomi; Hajime Koganei; Hirotaka Wagatsuma; Akira Mitsui; Tetsuya Ogawa; Kosaku Nitta; Tomoyuki Konda
Journal:  Heart Vessels       Date:  2010-10-05       Impact factor: 2.037

2.  Awareness of the Japanese Society of Hypertension Guidelines for the Management of Hypertension and their use in clinical practices: 2009 survey results.

Authors:  Taku Obara; Sergio Ramón Gutiérrez Ubeda; Takayoshi Ohkubo; Hideo Matsuura; Toshihiko Ishimitsu; Masanobu Takata; Hiromi Rakugi; Yutaka Imai
Journal:  Hypertens Res       Date:  2015-04-02       Impact factor: 3.872

3.  Effect of angiotensin II type 1 receptor blockers in patients with self-monitored morning hypertension.

Authors:  George Mansour; Janette Mansour
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 4.  Clinical significance of home blood pressure and its possible practical application.

Authors:  Yutaka Imai
Journal:  Clin Exp Nephrol       Date:  2013-07-03       Impact factor: 2.801

5.  Current status of aggressive blood pressure control.

Authors:  Steven G Chrysant
Journal:  World J Cardiol       Date:  2011-03-26

6.  Antihypertensive efficacy of the losartan/hydrochlorothiazide combination and its effect on plasma B-type natriuretic peptide in hypertensive patients uncontrolled by angiotensin II type 1 receptor antagonist-based therapy: a multicentre prospective observational study.

Authors:  Hiroshi Meno; Tetsuji Inou; Michiko Tanaka; Yoshihiro Tsuchiya; Yuhei Shiga; Kenji Kobayashi; Yuichiro Nakamura; Takeaki Ota; Ichiro Kubara
Journal:  Clin Drug Investig       Date:  2012-03-01       Impact factor: 2.859

7.  Prevalence, Determinants, and Clinical Significance of Masked Hypertension in a Population-Based Sample of African Americans: The Jackson Heart Study.

Authors:  Keith M Diaz; Praveen Veerabhadrappa; Michael D Brown; Matthew C Whited; Patricia M Dubbert; DeMarc A Hickson
Journal:  Am J Hypertens       Date:  2014-12-12       Impact factor: 2.689

8.  Understanding the decline of mean systolic blood pressure in Japan: an analysis of pooled data from the National Nutrition Survey, 1986-2002.

Authors:  Nayu Ikeda; Emmanuela Gakidou; Toshihiko Hasegawa; Christopher J L Murray
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

9.  The Effects of gamma-Aminobutyric Acid, Vinegar, and Dried Bonito on Blood Pressure in Normotensive and Mildly or Moderately Hypertensive Volunteers.

Authors:  Hiroko Tanaka; Kenichi Watanabe; Meilei Ma; Masao Hirayama; Takashi Kobayashi; Hiroshi Oyama; Yoshiko Sakaguchi; Mitsuo Kanda; Makoto Kodama; Yoshifusa Aizawa
Journal:  J Clin Biochem Nutr       Date:  2009-06-30       Impact factor: 3.114

10.  Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.

Authors:  Akira Nishiyama; Toshitaka Nakagawa; Hiroyuki Kobori; Yukiko Nagai; Noriyuki Okada; Yoshio Konishi; Takashi Morikawa; Michiaki Okumura; Isseiki Meda; Hideyasu Kiyomoto; Naohisa Hosomi; Takefumi Mori; Sadayoshi Ito; Masahito Imanishi
Journal:  J Hypertens       Date:  2008-09       Impact factor: 4.844
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.